Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGCHIX:MEDXZ +1.97%66 Buyback Yield % is 0.63 as of Jul. 31, 2026, which is 43% above its 10-year median of 0.44. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 744 Industrial Products companies, Medmix AG ranks better than 71.51% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Medmix AG's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:MEDXZ vs GEV, ETN, PH: Buyback Yield % Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Buyback Yield % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Medmix AG's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (CHIX:MEDXZ) has a Buyback Yield % of 0.63 as of Jul. 31, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medmix AG and its competitors. This is 43% above median its historical median of 0.44. According to the industry distribution chart, Medmix AG ranks #212 out of 744 companies in the Industrial Products industry, placing it in the top 28.5%.
Is Medmix AG's Buyback Yield % too high?
Medmix AG's current Buyback Yield % of 0.63 is 43% above median its 10-year median of 0.44. Based on the distribution chart, Medmix AG ranks #212 out of 744 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Buyback Yield % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #212 out of 744 companies for Buyback Yield %. This puts Medmix AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for an Industrial Products company?
A good Buyback Yield % depends on the Industrial Products industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medmix AG and its competitors. Medmix AG's current Buyback Yield % is 0.63, which is 43% above median its own 10-year median of 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current Buyback Yield % is 0.63, which is 43% above median its 10-year median of 0.44. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Buyback Yield % is 0.63 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
Buyback Yield %: 0.63 (43% above median its 10-year median of 0.44)
GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score
Get the complete analysis for CHIX:MEDXZ
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
